In a landmark partnership with the Government of Andhra Pradesh, AstraZeneca India is set to establish an Integrated Genomic Solutions Centre in Amaravati. The strategic collaboration, formalized through a Memorandum of Understanding (MoU), will power India’s first Integrated Precision Oncology programme. By leveraging cutting-edge genomic medicine and genetic research, the centre aims to advance personalized cancer diagnosis and targeted treatment—significantly elevating clinical outcomes and solidifying the state’s position as a premier hub for healthcare and life sciences innovation.
News by Rahul Yelligetti.